Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series

Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series

Huiying Li,1,* Tingting Yu,1,* Mingmin Huang,1 Aibin Guo,1 Xiaoping Qian,2 Zhenyu Yin1 1Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, People’s Republic of China; 2The Comprehensive Cancer Center of Drum Tower Hospita...

Full description

Bibliographic Details
Main Authors: Li H, Yu T, Huang M, Guo A, Qian X, Yin Z
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung cancer
leptomeningeal metastases
osimertinib
EGFR mutation
T790M
Online Access:https://www.dovepress.com/treatment-response-to-osimertinib-in-egfr-mutated-leptomeningeal-metas-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/treatment-response-to-osimertinib-in-egfr-mutated-leptomeningeal-metas-peer-reviewed-article-OTT

Similar Items